MedTrace Logo

Repetitive Transcranial Magnetic Stimulation for Dementia

NCT02621424 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-09-30

Study results available
· View outcomes & findings →

Summary

The purpose is to is to study if repetitive transcranial magnetic stimulation (rTMS) improves cognitive function in patients with neurodegenerative conditions which may manifest as mild to moderate cognitive impairment and, in late phase, dementia. This study also intends to investigate if the responses to rTMS intervention are either positively or negatively correlated with the initial severity of cognitive impairment.

Conditions

Interventions

DEVICE

RTMS

stimulation of the brain with magnetic pulses

DEVICE

sham

sham noise to block the sound of stimulation

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Jauhtai J Cheng, MD · VA Palo Alto Health Care System, Palo Alto, CA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2019-02-28
Completion
2025-09-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02621424 on ClinicalTrials.gov